Cite
HARVARD Citation
Westhovens, R. et al. (2013). AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial. Annals of the rheumatic diseases. p. A873. [Online].